Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,352 | -7,792 | -8,224 | -8,538 | -13,155 |
| Accounts receivable | -1,747 | -48 | -330 | -272 | N/A |
| Other Working Capital | -1,398 | 1,050 | 132 | -5,619 | 4,896 |
| Other Operating Activity | 3,039 | 1,806 | 1,825 | 2,076 | 1,629 |
| Operating Cash Flow | $-5,459 | $-4,985 | $-6,596 | $-12,353 | $-6,630 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,104 |
| Common Stock Issued | 14,742 | N/A | 7,444 | 14,740 | 3,931 |
| Other Financing Activity | -426 | -119 | -149 | -1,311 | 0 |
| Financing Cash Flow | $14,316 | $-119 | $7,295 | $13,429 | $9,035 |
| Beginning Cash Position | 4,739 | 9,844 | 9,145 | 8,069 | 5,664 |
| End Cash Position | 13,597 | 4,739 | 9,844 | 9,145 | 8,069 |
| Net Cash Flow | $8,857 | $-5,104 | $699 | $1,076 | $2,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,459 | -4,985 | -6,596 | -12,353 | -6,630 |
| Free Cash Flow | -5,459 | -4,985 | -6,596 | -12,353 | -6,630 |